Normal Leg Strength Values in People With Kidney Disease on Hemodialysis
Measures hip muscle strength in adults with chronic kidney disease having hemodialysis.
Plain-language title generated from the registry record
Registry title: Reference Values for Lower-Limb Dynamometry in Patients With Chronic Kidney Disease (REHAD-CKD)
Key facts
- Where
- Madrid, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with chronic kidney disease who have been on hemodialysis for at least 1 month. It measures hip muscle strength to set reference values.
- Age
- 18 Years to 85 Years
- Sex
- All sexes can join.
- Disease stage
- Chronic kidney disease treated with hemodialysis (3 weekly sessions of 4 hours).
- Earlier treatment
- At least 1 months on hemodialysis.
Main reasons for not taking part
- Lower-limb amputation
- Neurological, musculoskeletal or osteoarticular disorders
- Severe or unstable other illnesses, such as decompensated heart failure or diabetes, unstable angina, recent MI, uncontrolled hypertension, severe lung disease, acute infection
- Fewer than 2 dialysis sessions per week
- Inability to understand the assessments
This trial only enrols participants on dialysis. The registry sentence this rests on: ≥1 months on HD (3 weekly sessions of 4 hours)
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT07642778, who can take part
Where in Spain
- Diaverum MadridMadrid, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Cardenal Herrera University
- Trial code
- NCT07642778
- Record updated
- 12 June 2026
- Original description
Patients with chronic kidney disease (CKD) undergoing hemodialysis present musculoskeletal complications, such as sarcopenia, which impair their functionality and are associated with an increased risk of mortality. Functional assessment in this population is complex due to the organization of hemodialysis schedules and patients' dependence on medical transportation, which hinders evaluation outside the dialysis setting.Read full original descriptionShow less
Reference Values for Lower-Limb Dynamometry in Patients With Chronic Kidney Disease (REHAD-CKD)
Patients with chronic kidney disease (CKD) undergoing hemodialysis present musculoskeletal complications, such as sarcopenia, which impair their functionality and are associated with an increased risk of mortality. Functional assessment in this population is complex due to the organization of hemodialysis schedules and patients' dependence on medical transportation, which hinders evaluation outside the dialysis setting.
The assessment of lower limb strength is of great relevance, as an adequate level of muscle strength in this region is essential for performing many activities of daily living, including walking, sit-to-stand and stand-to-sit movements, as well as ascending and descending stairs. Our research group has published a study demonstrating the safety and reliability of intradialytic measurement of hip flexion and abduction strength; however, reference values for the dialysis population and for individuals with CKD in general are currently unknown.
The primary aim of this study is to propose reference values for hip flexor and abductor muscle strength measured using a hand-held dynamometer in individuals with chronic kidney disease (CKD). Secondary objectives include assessing the association between lower limb muscle strength measured with a hand-held dynamometer and handgrip strength, physical activity level, frailty, gait speed, performance in the 10-repetition sit-to-stand-to-sit test, ultrasound assessment of the rectus femoris muscle, and health-related quality of life.
Inclusion: ≥1 months on HD (3 weekly sessions of 4 hours).
Exclusion: Neurological, musculoskeletal or osteoarticular disorders; Severe/unstable comorbidities (e.g., decompensated heart failure or diabetes, unstable angina, recent MI, uncontrolled hypertension, severe lung disease, acute infection); Lower-limb amputation; <1 months on HD; <2 sessions/week,; Inability to understand assessments.